
Saliva-based diagnostics represent a truly promising and innovative field that is actively developing and shows great potential for detecting both metabolic and oncological diseases. Its key advantage is its non-invasive nature: collecting the biological sample is simple, painless, and carries no risk of infection—unlike blood sampling. This is particularly important for patients for whom frequent blood draws are difficult or impossible (such as children, the elderly, or individuals undergoing immunosuppressive therapy).
While saliva-based diagnostics is an actively evolving field, the full potential of this method has yet to be realized. The approach involves analyzing the composition of saliva to identify biomarkers, including DNA, RNA (such as microRNA), proteins, metabolites, and alterations in the microbiome. At present, however, it serves as an auxiliary method and cannot replace traditional, more precise, and specific diagnostic techniques (such as biopsies, CT scans, or MRIs).
This special issue aims to explore the current capabilities and future prospects of saliva-based diagnostics, as well as the primary challenges and limitations associated with its integration into clinical practice.

